MedPath

TARO-FAMPRIDINE

TARO-FAMPRIDINE

Approved
DIN Number

02482398

Drug Class

Human

Market Date

Nov 24, 2020

Company
HC

Taro Pharmaceuticals Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02482398
AIG Number0153090001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N07XX07 FAMPRIDINE
Product Specifications
Dosage FormTablet (Extended-Release)
Route of AdministrationOral
AHFS Classification92:56.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

FAMPRIDINEActive
Strength: 10 MG
Monograph: FAMPRIDINE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.